A premium exact match .com for organizations building AI enabled clinical trial platforms, trial intelligence systems, patient recruitment tools, site selection software, clinical data workflows, and regulatory ready trial operations.
Registered in 2016 · Exact match 8-letter .com · Full bundle includes AITrials.com + AITrials.ai + AITrials.app · Secured through Afternic / GoDaddy escrow
The complete three-extension bundle is secured through Afternic and GoDaddy escrow. Transaction is protected for both parties.
Buy It Now delivers the complete three-extension bundle — AITrials.com, AITrials.ai, and AITrials.app transfer immediately upon cleared payment. The transaction is secured through Afternic and GoDaddy escrow infrastructure.
Recent verified sales establish the market for premium AI domain assets. AITrials.com is a .com — structurally more valuable than a .ai — offered as a three-extension bundle covering a specific, regulated, high-spend category.
| Domain | Sale Price | Date | Extension | Why It Matters |
|---|---|---|---|---|
| AI.com | $70,000,000 | Apr 2025 | .com | Category king of all AI — proves category ownership has no ceiling |
| Bot.ai | $1,200,000 | Feb 2026 | .ai only | First .ai to break $1M publicly — single word, no .com, no bundle |
| Fin.ai | $1,000,000 | Mar 2025 | .ai only | Single-word vertical .ai — finance sector |
| Wisdom.ai | $750,000 | Oct 2025 | .ai only | Single-word abstract .ai — no vertical specificity |
| Cloud.ai | $600,000 | Jul 2025 | .ai only | Single-word generic .ai |
| Law.ai | $350,000 | Aug 2025 | .ai only | Single-word vertical .ai — legal sector, no .com, no bundle |
| AITools.com | $238,000 | Jul 2025 | .com | Two-word AI .com — investor-to-investor flip, not end-user price |
| AITrials.com + .ai + .app | $995,000 | Available Now | .com + .ai + .app | Three-extension bundle · Exact-match category name · Regulated sector |
The distinction that matters for strategic buyers: AITools.com at $238K was an investor-to-investor transaction — a domain flip. End-user acquisitions, where an organization secures a name to build their primary brand, reflect a different value entirely. Bot.ai sold for $1.2M as a single .ai extension with no matching .com. AITrials.com is a .com — the standard for enterprise healthcare — bundled with both matching extensions, covering a specific regulated category where the next $50B of enterprise software spend is actively flowing. A conservative strategic valuation range for the full AITrials.com bundle is USD $1.2M to USD $1.8M. The current USD $995,000 Buy It Now price is below the estimated strategic replacement value for the right buyer.
How to frame this acquisition internally for budget approval
AITrials.com is currently listed at USD $995,000 for the full acquisition bundle: AITrials.com, AITrials.ai, and AITrials.app.
For a strategic buyer, the value is not based on domain traffic. The value is category control, brand clarity, launch speed, extension protection, and the ability to own the exact language of AI-enabled clinical trials — the phrase regulators, sponsors, and sites are already using.
Comparable AI and premium category domains show that strategic buyers consistently pay seven figures for names that remove branding friction and deliver immediate market authority. A conservative strategic valuation range for the full AITrials.com bundle is USD $1.2M to USD $1.8M.
That places the current USD $995,000 Buy It Now price below the estimated strategic replacement value for the right CRO, pharma AI team, clinical trial software company, or life sciences AI platform. The complete three-extension bundle transfers immediately upon cleared payment.
Domain acquisitions of this type are typically recorded as intangible assets on the balance sheet, not expensed as marketing costs. The acquisition cost is fixed. The cost of a competitor owning this name is not.
AITrials.com is the shortest clean digital shorthand for AI enabled clinical trials. The term naturally maps to AI trial design, AI site selection, AI patient recruitment, AI clinical data review, AI safety monitoring, AI protocol optimization, and AI regulatory workflows.
For organizations building platforms in this space — whether CROs, pharmaceutical AI teams, clinical trial technology companies, or life sciences AI infrastructure firms — this domain offers immediate category alignment. It communicates what you do clearly and credibly to research sites, sponsors, regulators, and investors.
The asset can serve as:
A product umbrella for AI clinical trial software · A corporate initiative brand for AI trial operations · A category hub for thought leadership and lead generation · An investor-facing brand for clinical AI companies · A conference campaign platform · A defensive brand asset to prevent competitor ownership of the obvious category domain
AITrials.com is positioned as a strategic digital asset — not a speculative name. For qualified buyers in pharmaceutical AI, clinical trial technology, or life sciences infrastructure, this domain represents the cleanest possible front door to the AI enabled clinical trials category.
The EU AI Act’s high-risk system compliance deadline arrives August 2026 — organizations building AI clinical trial platforms must establish credible, regulatory-ready brand identities now. The FDA’s Operation TrialBlazer pilot program is actively soliciting industry partners for AI-enabled trial optimization. Meanwhile, the AP.com domain is currently at auction, establishing eight-figure precedent for category-defining names. Organizations that secure AITrials.com in Q3 2026 enter the regulatory conversation with the most credible digital identity in the category. The window to own this name before a competitor does is measured in months, not years.
Current regulatory and commercial developments supporting the AI clinical trials category
FDA announced pilot program for AI enabled optimization in clinical trial operations, with comment period extended to June 29, 2026.
Source: FDA.govZS, a global professional services firm, launched Trials.ai — a clinical trial intelligence platform powered by AI and analytics.
Source: ZS.comMedidata announced expanded AI capabilities for clinical trial imaging workflows and safety monitoring in 2026.
Source: Medidata.comAmerican Society of Clinical Oncology (ASCO) and Ryght announced collaboration on AI enabled clinical trial site selection platform.
Source: ASCO.orgAITrials.com says the category in 8 letters or two extremely short words. For pharmaceutical AI teams, CROs, and clinical trial technology platforms, this domain immediately communicates what you do — no explanation needed.
A clean .com matters in regulated clinical, pharmaceutical, and life sciences markets. AITrials.com carries the credibility required for engagement with sponsors, research sites, and regulatory bodies.
Owning the category domain prevents a competitor from controlling the obvious digital front door. In a competitive clinical AI market where ZS, Medidata, and ASCO are already moving, domain control is a first-mover strategic advantage — not a nice-to-have.
The full Buy It Now bundle delivers AITrials.com, AITrials.ai, and AITrials.app — all three extensions secured under one acquisition. No competitor can park a matching extension and siphon credibility. This is the only path to owning the complete brand across every major extension.
How organizations in this space might deploy AITrials.com
Review the strategic category fit, buyer use cases, acquisition structure, bundle details, and pricing logic for AITrials.com, AITrials.ai, and AITrials.app.
Domain Bundle Included
The acquisition includes the following three assets:
Buy It Now — USD $995,000
All three domains transfer after cleared payment and standard marketplace or registrar transfer requirements are completed. The Buy It Now acquisition includes the complete bundle: AITrials.com, AITrials.ai, and AITrials.app.
All transactions are secured through Afternic and GoDaddy supported escrow processes, providing verified transfer and escrow protection for both parties. Corporate due diligence is fully supported.
Prefer a direct conversation before going through Afternic? Qualified buyers — including pharmaceutical companies, CROs, and clinical AI platforms — are welcome to reach out directly for acquisition details, due diligence support, or to discuss terms. Contact: Send Acquisition Inquiry
Yes. AITrials.com is available for acquisition through the official Afternic listing. AITrials.com currently redirects to the Afternic acquisition page. The Buy It Now price is $995,000 for the complete three-extension bundle: AITrials.com, AITrials.ai, and AITrials.app.
AITrials.com is positioned for pharmaceutical companies, Contract Research Organizations (CROs), clinical trial technology platforms, clinical data companies, AI health companies, AI site selection platforms, AI patient recruitment companies, clinical imaging AI companies, and life sciences AI infrastructure firms building products or initiatives in the AI enabled clinical trials category.
The Buy It Now price of $995,000 includes the full three-extension bundle: AITrials.com, AITrials.ai, and AITrials.app. All three extensions transfer immediately upon cleared payment.
The acquisition is handled through Afternic and GoDaddy supported processes. Transactions are secured through industry-standard escrow services, providing protection for both buyer and seller throughout the transfer process. Corporate due diligence is fully supported.
Yes. Qualified buyers can work through Afternic broker communication for acquisition details, domain verification, and corporate due diligence support. For direct inquiries prior to the formal Afternic process, contact us using the acquisition inquiry link in the Acquisition Path section above.
Click through to AITrials.com (which redirects to the official Afternic listing) or use the “Begin Acquisition on Afternic” buttons on this page. From there, you can review the Buy It Now listing, contact the Afternic broker, and begin the secure acquisition process. For a direct conversation before going through Afternic, use the acquisition inquiry contact in the Acquisition Path section.
The EU AI Act compliance deadline is August 2026. The FDA’s Operation TrialBlazer pilot is active now. The organizations that establish their AI clinical trials brand in Q3 2026 will own the category conversation for the next decade. AITrials.com is available today — at a price that is below the estimated strategic replacement value for the right buyer.